Skip to main content
Article thumbnail
Location of Repository

Trends in laboratory testing for diabetes in Ontario, Canada 1995–2005: A population-based study

By Sarah E Wilson, Lorraine L Lipscombe, Laura C Rosella and Douglas G Manuel
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). A: Diabetes in Ontario. Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care
  2. (2002). Agency of Canada: Organized breast cancer screening programs in Canada:
  3. (1998). Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance
  4. (2003). Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian Diabetes Association
  5. (2008). Cho YW: Diagnostic value of glycated haemoglobin (HbA1c) for the early detection of diabetes in high-risk subjects. Diabet Med
  6. (1999). CL: Prevalence and trends in obesity among US adults,
  7. (2005). Comparison of papanicolaou (Pap) test rates across Ontario and factors associated with cervical screening.
  8. (2007). Dharmage SC: HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med
  9. (1992). Expert Committee of the Canadian Diabetes Advisory Board: Clinical practice guidelines for treatment of diabetes mellitus. CMAJ
  10. (1998). Ferrara A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care
  11. (1999). Flegal KM: Prevalence of overweight and obesity in the United States,
  12. (1998). Group on behalf of the European Diabetes Epidemiology Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ
  13. H: Global prevalence of diabetes: estimates for the year 2000 and projections for
  14. (2007). Hux JE: Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a populationbased study. Lancet
  15. (2007). Inadequacy of cervical cancer screening among urban recent immigrants: A population-based study of physician and laboratory claims in Toronto, Canada. Prev Med
  16. (1992). Knuiman MW: Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care
  17. (2007). Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. Family Practice
  18. (2001). Mustard CA: Undiagnosed diabetes: Does it matter? CMAJ
  19. (2007). Ontario Ministry of Health and Long Term Care: Schedule of Laboratory Fees, Preamble [ program/ohip/sob/lab/lab_mn.html]. Accessed
  20. (2003). Overweight and obesity in Australia: the 1999–2000 Australian diabetes, obesity and lifestyle study (AusDiab).
  21. (1990). Performance measures from 10 years of breast screening in the Ontario Breast Screening Program,
  22. (2006). Prevalence of class I, II and III obesity in Canada. CMAJ
  23. (2005). SA: Prevalence of obesity in Great Britain. Obes Rev
  24. (1998). Steering and Expert Committees:
  25. (2005). the Canadian Task Force on Preventive Health Care: Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. CMAJ
  26. (2003). The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care
  27. (1997). The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care
  28. (2001). Tildesley HD, Fontaine N: Diabetes screening in Canada (DIASCAN) Study. Diabetes Care
  29. (1998). WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.